Floatz logo

cb-10-01

Stage IIIB Skin Melanoma

Cosmo BioscienceCell therapyPhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

450 Active assets in the Stage IIIB Skin Melanoma cohort.

Asset / SponsorPhaseRating
Gm-Csf
Ultimovacs ASA
Phase 4BBB
Cediranib
M.D. Anderson Cancer Center
Phase 3BBB
Sargramostim
Mayo Clinic
Phase 3BBB
Ifa
Craig L Slingluff, Jr
Phase 2BB
Temsirolimus
University of Regensburg
Phase 2BB

View all 50 →

Same molecule, other indications

cb-10-01 is also rated in:

cutaneous melanomaDormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →